PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
26130441-10	2016	CONCLUSIONS: The sensitivity for preoperative detection of HCCs was higher for gadoxetic acid-enhanced MRI than for multiphasic MDCT imaging.	gadolinium ethoxybenzyl DTPA	79-93	holocytochrome c synthase	Homo sapiens	59-63	
32166493-14	2020	CONCLUSION: Noncontrast and abbreviated MRI using gadoxetic acid showed comparable diagnostic performance for detecting patients with HCCs in the early stage.	gadolinium ethoxybenzyl DTPA	50-64	holocytochrome c synthase	Homo sapiens	134-138	
32166493-15	2020	KEY POINTS:   Diagnostic performance of noncontrast MRI and abbreviated MRI using gadoxetic acid for detecting HCCs is comparable in patients with HCCs in the early stage.	gadolinium ethoxybenzyl DTPA	82-96	holocytochrome c synthase	Homo sapiens	111-115	
32033745-9	2020	CONCLUSION: A considerable proportion of HCCs could have been categorised as LR-M as they had a targetoid appearance on gadoxetic acid-enhanced MRI.	gadolinium ethoxybenzyl DTPA	120-134	holocytochrome c synthase	Homo sapiens	41-45	
27957635-7	2017	CONCLUSION: Although enhancement patterns of recurrent HCC in transplanted liver did not affect OS and TTR, these HCCs that arise after LT frequently revealed atypical enhancement on gadoxetic acid-enhanced MR imaging.	gadolinium ethoxybenzyl DTPA	183-197	holocytochrome c synthase	Homo sapiens	114-118	
27957635-8	2017	KEY POINTS:   Recurrent HCCs after LT showed atypical enhancement on gadoxetic acid-enhanced MRI.	gadolinium ethoxybenzyl DTPA	69-83	holocytochrome c synthase	Homo sapiens	24-28	
25668519-11	2015	CONCLUSION: HCCs with beta-catenin mutation showed a higher grade of differentiation with frequent pseudoglandular patterns and bile production, and characteristic imaging findings included a high enhancement ratio at gadoxetic acid-enhanced MR imaging and a high apparent diffusion coefficient at diffusion-weighted imaging.	gadolinium ethoxybenzyl DTPA	218-232	holocytochrome c synthase	Homo sapiens	12-16	
25203131-0	2015	Diagnostic performance of gadoxetic acid-enhanced liver MR imaging in the detection of HCCs and allocation of transplant recipients on the basis of the Milan criteria and UNOS guidelines: correlation with histopathologic findings.	gadolinium ethoxybenzyl DTPA	26-40	holocytochrome c synthase	Homo sapiens	87-91	
25231411-11	2015	CONCLUSIONS: Although AMLs showed similar enhancement patterns to HCCs during the dynamic phases of gadoxetic acid-enhanced MRI, using characteristic MR features of AML during the HBP and demographic differences, one can better differentiate AML from HCC.	gadolinium ethoxybenzyl DTPA	100-114	holocytochrome c synthase	Homo sapiens	66-70	
20380933-7	2010	Four HCCs were clearly revealed as hypointense only on gadoxetic acid-enhanced hepatocyte phase imaging, but were occult on other sequences, including the SPIO set.	gadolinium ethoxybenzyl DTPA	55-69	holocytochrome c synthase	Homo sapiens	5-9	
22847903-1	2012	BACKGROUND: As gadoxetic acid-enhanced magnetic resonance imaging (MRI) and diffusion-weighted imaging (DWI) have been widely used for the evaluation of hepatocellular carcinoma (HCC), it is clinically relevant to determine the diagnostic efficacy of gadoxetic acid-enhanced MRI and DWI for detection of HCCs with respect to the severity of liver cirrhosis.	gadolinium ethoxybenzyl DTPA	15-29	holocytochrome c synthase	Homo sapiens	304-308	
22847903-2	2012	PURPOSE: To compare the diagnostic accuracy and sensitivity of gadoxetic acid-enhanced MRI and DWI for detection of HCCs with respect to the severity of liver cirrhosis.	gadolinium ethoxybenzyl DTPA	63-77	holocytochrome c synthase	Homo sapiens	116-120	
23401584-9	2013	CONCLUSION: HCCs can be classified into several imaging patterns on gadoxetic acid-enhanced MR images, which are associated with tumor aggressiveness and outcome.	gadolinium ethoxybenzyl DTPA	68-82	holocytochrome c synthase	Homo sapiens	12-16	
20380933-8	2010	CONCLUSION: Gadoxetic acid-enhanced MRI is better than SPIO-enhanced MRI for the detection of HCCs.	gadolinium ethoxybenzyl DTPA	12-26	holocytochrome c synthase	Homo sapiens	94-98